PRP in ACLR to Prevent PTOA
NCT05412381
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of our study is to examine the effect of platelet-rich-plasma (PRP) injection on the short-term resolution of post-injury inflammation (biomarkers) and improvement in joint function in patients with acute ACL injury. This RCT has been powered based on the questionnaire KOOS Jr. but it is considered a 'pilot study' in terms of the lab analysis proposed.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Anterior Cruciate Ligament Injuries
- Post-traumatic Osteoarthritis
- PRP
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 3
- Ages
- 14 to 50 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Hospital for Special Surgery, New York
- Last updated on ClinicalTrials.gov
- February 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Hospital for Special Surgery · New York, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.